Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AMGEN INC
Report date May 09, 2006 · Filed May 11, 2006
Section 16 reporting ended · disclosed 2006-05-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 1,604,988 |
Reported balance
After 2006-05-09 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2006-05-09 · Gift · Disposed 28,300 · Balance 1,604,988 |
| Common StockSEC Table I · non-derivative | IndirectBy Partnership | 350,000 |
Reported balance
Holding disclosure · report date 2006-05-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 350,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2006 Filed Feb 22, 2006 20:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $74.54 | $29,816.00 |
DisclosureSEC source: 0001181431-06-013474 · rrd108963.xml · nonDerivative · entry 12 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,650,361 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $74.53 | $74,530.00 |
DisclosureSEC source: 0001181431-06-013474 · rrd108963.xml · nonDerivative · entry 11 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,650,761 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 600 | $74.52 | $44,712.00 |
DisclosureSEC source: 0001181431-06-013474 · rrd108963.xml · nonDerivative · entry 10 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,651,761 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,042 | $74.51 | $77,639.42 |
DisclosureSEC source: 0001181431-06-013474 · rrd108963.xml · nonDerivative · entry 9 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,652,361 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,358 | $74.50 | $175,671.00 |
DisclosureSEC source: 0001181431-06-013474 · rrd108963.xml · nonDerivative · entry 8 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,653,403 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $74.49 | $74,490.00 |
DisclosureSEC source: 0001181431-06-013474 · rrd108963.xml · nonDerivative · entry 7 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,655,761 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,400 | $74.48 | $104,272.00 |
DisclosureSEC source: 0001181431-06-013474 · rrd108963.xml · nonDerivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,656,761 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,500 | $74.47 | $111,705.00 |
DisclosureSEC source: 0001181431-06-013474 · rrd108963.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,658,161 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,500 | $74.46 | $260,610.00 |
DisclosureSEC source: 0001181431-06-013474 · rrd108963.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,659,661 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 600 | $74.45 | $44,670.00 |
DisclosureSEC source: 0001181431-06-013474 · rrd108963.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,663,161 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 600 | $74.44 | $44,664.00 |
DisclosureSEC source: 0001181431-06-013474 · rrd108963.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,663,761 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 20:13 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $74.43 | $29,772.00 |
DisclosureSEC source: 0001181431-06-013474 · rrd108963.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,664,361 Read SEC document |
| January 19, 2006 Filed Apr 20, 2006 19:47 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-024456 · rrd114749.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,633,288 Read SEC document |
| January 12, 2006 Filed Jan 13, 2006 23:48 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 9,600 | $14.72 Strike: $14.72 | $141,300.48 |
DisclosureSEC source: 0001181431-06-003592 · rrd103627.xml · derivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,600 shares Expires 2006-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2006 Filed Jan 13, 2006 23:48 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 9,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-003592 · rrd103627.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,676,961 F1 · kind: These shares are being transferred to the reporting persons trust. Read SEC document |
| January 12, 2006 Filed Jan 13, 2006 23:48 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 9,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-003592 · rrd103627.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These shares are being transferred to the reporting persons trust. Read SEC document |
| January 12, 2006 Filed Jan 13, 2006 23:48 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 9,600 | $14.72 | $141,300.48 |
DisclosureSEC source: 0001181431-06-003592 · rrd103627.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $81.68 | $8,168.00 |
DisclosureSEC source: 0001181431-05-061325 · rrd97178.xml · nonDerivative · entry 9 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,667,361 Read SEC document |
| November 14, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,487 | $81.65 | $203,063.55 |
DisclosureSEC source: 0001181431-05-061325 · rrd97178.xml · nonDerivative · entry 8 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,667,461 Read SEC document |
| November 14, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,100 | $81.64 | $824,564.00 |
DisclosureSEC source: 0001181431-05-061325 · rrd97178.xml · nonDerivative · entry 7 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,669,948 Read SEC document |
| November 14, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 300 | $81.61 | $24,483.00 |
DisclosureSEC source: 0001181431-05-061325 · rrd97178.xml · nonDerivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,680,048 Read SEC document |
| November 14, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $81.60 | $81,600.00 |
DisclosureSEC source: 0001181431-05-061325 · rrd97178.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,680,348 Read SEC document |
| November 14, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,500 | $81.58 | $856,590.00 |
DisclosureSEC source: 0001181431-05-061325 · rrd97178.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,681,348 Read SEC document |
| November 14, 2005 Filed Nov 15, 2005 02:07 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 513 | $81.57 | $41,845.41 |
DisclosureSEC source: 0001181431-05-061325 · rrd97178.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,691,848 Read SEC document |
| November 08, 2005 Filed Nov 9, 2005 21:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 11,098 | $80.40 | $892,279.20 |
DisclosureSEC source: 0001181431-05-060515 · rrd96653.xml · nonDerivative · entry 11 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,692,361 Read SEC document |
| November 08, 2005 Filed Nov 9, 2005 21:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 200 | $80.38 | $16,076.00 |
DisclosureSEC source: 0001181431-05-060515 · rrd96653.xml · nonDerivative · entry 10 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,703,459 Read SEC document |
| November 08, 2005 Filed Nov 9, 2005 21:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 200 | $80.35 | $16,070.00 |
DisclosureSEC source: 0001181431-05-060515 · rrd96653.xml · nonDerivative · entry 9 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,703,659 Read SEC document |
| November 08, 2005 Filed Nov 9, 2005 21:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,400 | $80.31 | $192,744.00 |
DisclosureSEC source: 0001181431-05-060515 · rrd96653.xml · nonDerivative · entry 8 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,703,859 Read SEC document |
| November 08, 2005 Filed Nov 9, 2005 21:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $80.25 | $401,250.00 |
DisclosureSEC source: 0001181431-05-060515 · rrd96653.xml · nonDerivative · entry 7 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,706,259 Read SEC document |
| November 08, 2005 Filed Nov 9, 2005 21:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 200 | $80.14 | $16,028.00 |
DisclosureSEC source: 0001181431-05-060515 · rrd96653.xml · nonDerivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,711,259 Read SEC document |
| November 08, 2005 Filed Nov 9, 2005 21:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 802 | $80.13 | $64,264.26 |
DisclosureSEC source: 0001181431-05-060515 · rrd96653.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,711,459 Read SEC document |
| November 08, 2005 Filed Nov 9, 2005 21:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $80.12 | $8,012.00 |
DisclosureSEC source: 0001181431-05-060515 · rrd96653.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,712,261 Read SEC document |
| November 08, 2005 Filed Nov 9, 2005 21:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $80.05 | $400,250.00 |
DisclosureSEC source: 0001181431-05-060515 · rrd96653.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,712,361 Read SEC document |
| September 28, 2005 Filed Sep 30, 2005 16:57 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 3,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-054206 · rrd93426.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,717,361 Read SEC document |
| September 07, 2005 Filed Sep 8, 2005 18:41 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-050932 · rrd91479.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,720,561 Read SEC document |
| September 07, 2005 Filed Sep 8, 2005 18:41 UTC | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-050932 · rrd91479.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,733,061 F2 · kind: (FJP 09/05 Dist) On September 7, 2005, Asset Management Partners ("AMP") distributed shares of Amgen Common Stock to a partner of the partnership. Accordingly, 50,000 shares are now held indirectly by the Johnson Revocable Trust. AMP, of which the reporting person is the general partner, currently holds 350,000 shares of Amgen Common Stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. F2 · balance_after: (FJP 09/05 Dist) On September 7, 2005, Asset Management Partners ("AMP") distributed shares of Amgen Common Stock to a partner of the partnership. Accordingly, 50,000 shares are now held indirectly by the Johnson Revocable Trust. AMP, of which the reporting person is the general partner, currently holds 350,000 shares of Amgen Common Stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 07, 2005 Filed Sep 8, 2005 18:41 UTC | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-050932 · rrd91479.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 350,000 F2 · kind: (FJP 09/05 Dist) On September 7, 2005, Asset Management Partners ("AMP") distributed shares of Amgen Common Stock to a partner of the partnership. Accordingly, 50,000 shares are now held indirectly by the Johnson Revocable Trust. AMP, of which the reporting person is the general partner, currently holds 350,000 shares of Amgen Common Stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. F2 · balance_after: (FJP 09/05 Dist) On September 7, 2005, Asset Management Partners ("AMP") distributed shares of Amgen Common Stock to a partner of the partnership. Accordingly, 50,000 shares are now held indirectly by the Johnson Revocable Trust. AMP, of which the reporting person is the general partner, currently holds 350,000 shares of Amgen Common Stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 02, 2005 Filed Aug 3, 2005 16:28 UTC | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-044003 · rrd87978.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,683,061 F2 · kind: (FJP 08/05 Dist) On August 2, 2005, Asset Management Partners ("AMP") distributed shares of Amgen Common Stock to the partners of the partnership. Accordingly, 50,000 shares are now held indirectly by the Johnson Revocable Trust, and an aggregate of 50,000 shares were distributed to the other partners. AMP, of which the reporting person is the general partner, holds 400,000 shares of Amgen Common Stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 02, 2005 Filed Aug 3, 2005 16:28 UTC | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-044003 · rrd87978.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 400,000 F2 · kind: (FJP 08/05 Dist) On August 2, 2005, Asset Management Partners ("AMP") distributed shares of Amgen Common Stock to the partners of the partnership. Accordingly, 50,000 shares are now held indirectly by the Johnson Revocable Trust, and an aggregate of 50,000 shares were distributed to the other partners. AMP, of which the reporting person is the general partner, holds 400,000 shares of Amgen Common Stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 29, 2005 Filed Aug 1, 2005 22:55 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-043393 · rrd87632.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,633,061 Read SEC document |
| July 25, 2005 Filed Jul 26, 2005 00:19 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 27,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-041883 · rrd86803.xml · nonDerivative · entry 7 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,636,061 Read SEC document |
| June 23, 2005 Filed Jul 26, 2005 00:19 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-041883 · rrd86803.xml · nonDerivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,663,976 F1 · kind: (FPJ 3.07.05) Shares are being transferred to the Johnson Revocable Trust dated June 25, 2003. Read SEC document |
| June 23, 2005 Filed Jul 26, 2005 00:19 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-041883 · rrd86803.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: (FPJ 3.07.05) Shares are being transferred to the Johnson Revocable Trust dated June 25, 2003. Read SEC document |
| June 22, 2005 Filed Jul 26, 2005 00:19 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 712,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-041883 · rrd86803.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 1,662,270 F1 · kind: (FPJ 3.07.05) Shares are being transferred to the Johnson Revocable Trust dated June 25, 2003. Read SEC document |
| June 22, 2005 Filed Jul 26, 2005 00:19 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 712,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-041883 · rrd86803.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 F1 · kind: (FPJ 3.07.05) Shares are being transferred to the Johnson Revocable Trust dated June 25, 2003. Read SEC document |
| May 25, 2005 Filed May 27, 2005 15:54 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-031189 · rrd80417.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 950,227 Read SEC document |
| May 09, 2005 Filed May 9, 2005 22:11 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 35,000 | $58.85 | $2,059,785.00 |
DisclosureSEC source: 0001181431-05-026727 · rrd78257.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 500,000 Read SEC document |
| May 09, 2005 Filed May 9, 2005 22:11 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 41,000 | $58.77 | $2,409,570.00 |
DisclosureSEC source: 0001181431-05-026727 · rrd78257.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 535,000 Read SEC document |
| May 05, 2005 Filed May 9, 2005 16:25 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-026534 · rrd78104.xml · nonDerivative · entry 7 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 952,627 F2 · kind: (FPJ 3.07.05) Shares are being transferred to the Johnson Revocable Trust dated June 25, 2003. Read SEC document |
| May 05, 2005 Filed May 9, 2005 16:25 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-026534 · rrd78104.xml · nonDerivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 936,627 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.